Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Artificial Sweetener Aspartame to be Declared a Possible Cancer Risk by WHO Later This Month WHO’s IARC reportedly analyzed over 1,000 studies on aspartame’s cancer risk in a recent review of the artificial sweetener’s risks and benefits to consumers July 7, 2023 Stephanie Yanovich Add Your Comments A group of international health experts is expected to declare aspartame a potential cancer risk in the coming weeks, increasing concerns about the widespread use of the artificial sweetener commonly known by the brand name Equal, Nutrasweet and Sugar Twin, which is commonly found in diet sodas, fruit juices, gum and other products. According to a report by Reuters news, the World Health Organization (WHO) will publicly list aspartame as “possibly carcinogenic” to humans on July 14. The “possibly carcinogenic” classification for aspartame means the group believes the product has the potential to cause cancer, and the decision is reportedly based on a comprehensive review of scientific research conducted by the International Agency for Research on Cancer (IARC), the WHO’s cancer research division. Food industry executives are already criticizing the expected announcement regarding the aspartame cancer risk, arguing that it is generally safe to ingest in limited amounts. However, various studies have linked aspartame and cancer, even at low consumption levels. The food industry has long marketed artificial sweeteners like aspartame as not only safe, but also beneficial for health goals like weight loss. But the WHO recently determined that using artificial sweeteners for long term weight loss is ineffective for most people. The group recommended natural sugar intake reduction for slimming, instead of using artificial sweeteners linked to increased risk of heart disease, diabetes, and high blood pressure, in addition to cancer. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Upcoming Aspartame Cancer Risk Classification Faces Industry Criticism The IARC has four classification levels – carcinogenic, probably carcinogenic, possibly carcinogenic, and not classifiable. Risk categories are assigned based on the strength of scientific research linking a substance to cancer. For a product to receive aspartame’s expected “possibly carcinogenic” classification, scientific evidence must meet certain standards, according to the report. Specifically, there must be limited evidence showing its cancer-causing potential in humans, sufficient evidence showing its cancer causing potential in animals, or strong overall evidence regarding its cancer-causing properties. The IARC reportedly reviewed over 1,300 studies in assessing aspartame’s cancer risk. Food industry insiders reportedly argue that the WHO and IARC don’t specialize in food safety and aren’t qualified to determine aspartame’s potential health hazards. They’ve criticized prior WHO and IARC cancer causing classifications, such as red meat consumption receiving a “probably carcinogenic” rating, as raising needless consumer alarm. Advocates for the food industry also pointed out that the IARC cannot determine safe product consumption levels. Instead, another WHO division, the Joint WHO and Food and Agriculture Organization’s Expert Committee on Food Additives (JECFA), makes that decision. The JECFA has long stated that aspartame is safe for limited daily ingestion, a ruling food company executives argue will conflict with WHO’s expected cancer classification and confuse consumers. However, JECFA also reportedly completed a recent review of aspartame’s risks and benefits. It is expected to release its findings on July 14, the same day the WHO and IARC are anticipated to announce aspartame’s possible cancer risks. The JECFA announcement may include new, reduced aspartame consumption level guidelines aligning with the WHO and IARC ruling, Reuters reported. Despite initial reported pushback from the food industry regarding the expected aspartame cancer risk classification, it may eventually reformulate its products to alleviate consumer concern, according to the Reuters report. Health experts point out that Pepsi hasn’t used aspartame in its products since 2020, possibly in response to increased consumer anxiety regarding its associated adverse health effects. Classifying popular substances like aspartame as a possible cancer risk ultimately benefits consumers, they indicate, as it motivates more research that may conclusively confirm the extent of a product’s dangers. Tags: Artificial Sweetener, Aspartame, Cancer, Nutrasweet, World Health Organization More Lawsuit Stories Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis May 1, 2025 Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects May 1, 2025 Roundup Exposure May Increase Infertility, Endometriosis Risks: Study May 1, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (Posted: today) A Wisconsin woman has filed a Depo-Provera brain tumor lawsuit, alleging that she continued using the birth control injection for years after her diagnosis due to the manufacturers’ failure to provide adequate warnings about the potential risk of developing a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)Depo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025) Sports Gambling Addiction Crisis Fueled By Sportsbook App Lobbying Efforts: Report (Posted: yesterday) Following the rapid expansion of legalized sports betting across the U.S., a new watchdog report reveals how the gambling industry lobbied against consumer protections to prevent sports betting addictions, while wagers reached $148 billion annually. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Alleges Enormous Revenue Generated by Misleading Gamblers (04/23/2025)DraftKings and FanDuel Lawsuit Alleges Sportsbooks Engage in Deceptive Practices To Exploit Gambling Addiction (04/09/2025)Gambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025) Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (Posted: yesterday) A group of 11 lawsuits over complications associated with Bard PowerPort and other implantable port catheters will be prepared for a series of early bellwether trials in the federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)Bard PowerPort Bellwether Trial Selections To Be Made in Late April 2025 (03/26/2025)Smiths Medical Port Catheter Recall Issued Over Manufacturing Error (03/20/2025)
Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis May 1, 2025
Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (Posted: today) A Wisconsin woman has filed a Depo-Provera brain tumor lawsuit, alleging that she continued using the birth control injection for years after her diagnosis due to the manufacturers’ failure to provide adequate warnings about the potential risk of developing a meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)Depo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)
Sports Gambling Addiction Crisis Fueled By Sportsbook App Lobbying Efforts: Report (Posted: yesterday) Following the rapid expansion of legalized sports betting across the U.S., a new watchdog report reveals how the gambling industry lobbied against consumer protections to prevent sports betting addictions, while wagers reached $148 billion annually. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Alleges Enormous Revenue Generated by Misleading Gamblers (04/23/2025)DraftKings and FanDuel Lawsuit Alleges Sportsbooks Engage in Deceptive Practices To Exploit Gambling Addiction (04/09/2025)Gambling Addiction Lawsuit Filed Against Sports Betting Platform DraftKings (02/20/2025)
Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (Posted: yesterday) A group of 11 lawsuits over complications associated with Bard PowerPort and other implantable port catheters will be prepared for a series of early bellwether trials in the federal MDL. MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)Bard PowerPort Bellwether Trial Selections To Be Made in Late April 2025 (03/26/2025)Smiths Medical Port Catheter Recall Issued Over Manufacturing Error (03/20/2025)